Unity Biotechnology (STU:9U90) Marketable Securities : €26.59 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Unity Biotechnology's Marketable Securities for the quarter that ended in Mar. 2024 was €26.59 Mil.

Unity Biotechnology's annual Marketable Securities increased from Dec. 2021 (€48.83 Mil) to Dec. 2022 (€77.46 Mil) but then declined from Dec. 2022 (€77.46 Mil) to Dec. 2023 (€21.46 Mil).

Unity Biotechnology Marketable Securities Historical Data

The historical data trend for Unity Biotechnology's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Marketable Securities Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

81.01

65.67

48.83

77.46

21.46

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															56.43	46.13	35.67	21.46	26.59

Unity Biotechnology Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Unity Biotechnology (STU:9U90) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Unity Biotechnology Marketable Securities Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines